Health and wellness companies are embracing weight-loss drugs and building offerings around them in an effort to avoid the ...

Amid concerns over trade restrictions and a weakening economy, some investors are seeking stability in dividend-paying stocks—a traditional defensive strategy.

which has asked for a ban on other parties making copies of its tirzepatide-based therapies Mounjaro for diabetes and Zepbound for obesity, as well as dozens of legal challenges from Novo Nordisk ...

Health retailer The Vitamin Shoppe has seen a spike in demand for supplements that could help with loss of appetite, ...